[go: up one dir, main page]

BR9815335A - Uso de antagonistas de receptor de endotelina. - Google Patents

Uso de antagonistas de receptor de endotelina.

Info

Publication number
BR9815335A
BR9815335A BR9815335-8A BR9815335A BR9815335A BR 9815335 A BR9815335 A BR 9815335A BR 9815335 A BR9815335 A BR 9815335A BR 9815335 A BR9815335 A BR 9815335A
Authority
BR
Brazil
Prior art keywords
receptor antagonists
endothelin receptor
obesity
endothelin
diseases caused
Prior art date
Application number
BR9815335-8A
Other languages
English (en)
Inventor
Klaus M Nter
Michael Kirchengast
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of BR9815335A publication Critical patent/BR9815335A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"USO DE ANTAGONISTAS DE RECEPTOR DE ENDOTELINA" O uso de antagonistas de receptor de endotelina para produzir drogas para controlar obesidade e doenças causadas por obesidade.
BR9815335-8A 1997-12-05 1998-11-21 Uso de antagonistas de receptor de endotelina. BR9815335A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19754082A DE19754082A1 (de) 1997-12-05 1997-12-05 Methode zur Bekämpfung der Fettleibigkeit
PCT/EP1998/007501 WO1999029308A2 (de) 1997-12-05 1998-11-21 Methode zur bekämpfung der fettleibigkeit

Publications (1)

Publication Number Publication Date
BR9815335A true BR9815335A (pt) 2000-10-17

Family

ID=7850913

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9815335-8A BR9815335A (pt) 1997-12-05 1998-11-21 Uso de antagonistas de receptor de endotelina.

Country Status (16)

Country Link
US (1) US6197780B1 (pt)
EP (1) EP1035851B1 (pt)
JP (1) JP2002512173A (pt)
KR (1) KR20010032779A (pt)
CN (1) CN1152685C (pt)
AT (1) ATE204172T1 (pt)
AU (1) AU751053B2 (pt)
BR (1) BR9815335A (pt)
CA (1) CA2311423C (pt)
CZ (1) CZ300442B6 (pt)
DE (2) DE19754082A1 (pt)
ES (1) ES2162493T3 (pt)
HU (1) HUP0100171A3 (pt)
NO (2) NO324694B1 (pt)
RU (1) RU2292891C2 (pt)
WO (1) WO1999029308A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19533023B4 (de) * 1994-10-14 2007-05-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
US20050175667A1 (en) * 2004-02-10 2005-08-11 Wenda Carlyle Use of endothelin antagonists to prevent restenosis
CA2697057A1 (en) 2007-08-22 2009-02-26 Gilead Colorado, Inc. Therapy for complications of diabetes
KR102033806B1 (ko) 2011-11-11 2019-10-17 길리어드 아폴로, 엘엘씨 Ａｃｃ 억제제 및 이의 용도
EA201700155A1 (ru) * 2014-10-20 2017-10-31 Товарищество С Ограниченной Ответственностью "Фармацевтическая Компания "Ромат" Фармацевтическая композиция для лечения туберкулеза
AR106472A1 (es) 2015-10-26 2018-01-17 Gilead Apollo Llc Inhibidores de acc y usos de los mismos
KR20180086191A (ko) 2015-11-25 2018-07-30 길리어드 아폴로, 엘엘씨 2,4-디옥소-1,4-디히드로티에노[2,3-d]피리미딘 유도체를 함유하는 살진균 조성물
EP3380478B1 (en) 2015-11-25 2020-12-23 Gilead Apollo, LLC Ester acc inhibitors and uses thereof
EA201890913A1 (ru) 2015-11-25 2018-11-30 Джилид Аполло, Ллс Пиразоловые соединения в качестве ингибиторов акк и их применение
BR112018010453B1 (pt) 2015-11-25 2022-06-14 Gilead Apollo, Llc Compostos triazólicos inibindores de acetil coa carboxilase (acc)
AU2017226267B2 (en) 2016-03-02 2021-06-24 Gilead Apollo, Llc Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof
EP4122464B1 (en) 2017-03-28 2024-05-15 Gilead Sciences, Inc. Therapeutic combinations for treating liver diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0670320A4 (en) * 1992-12-01 1997-05-02 Green Cross Corp DERIVATIVE OF 1,8-NAPHTHYRIDIN-2-ONE AND USE OF THIS DERIVATIVE.
WO1997008169A1 (en) 1995-08-24 1997-03-06 Warner-Lambert Company Furanone endothelin antagonists
JP3116347B2 (ja) * 1996-11-13 2000-12-11 田辺製薬株式会社 医薬組成物

Also Published As

Publication number Publication date
CZ300442B6 (cs) 2009-05-20
EP1035851A2 (de) 2000-09-20
AU2153599A (en) 1999-06-28
HK1037141A1 (en) 2002-02-01
CN1301162A (zh) 2001-06-27
KR20010032779A (ko) 2001-04-25
WO1999029308A3 (de) 1999-09-30
CA2311423C (en) 2008-01-29
ES2162493T3 (es) 2001-12-16
DE19754082A1 (de) 1999-06-10
US6197780B1 (en) 2001-03-06
JP2002512173A (ja) 2002-04-23
HUP0100171A2 (hu) 2003-02-28
WO1999029308A2 (de) 1999-06-17
CZ20002006A3 (cs) 2000-11-15
NO20002777D0 (no) 2000-05-30
AU751053B2 (en) 2002-08-08
HUP0100171A3 (en) 2003-10-28
CA2311423A1 (en) 1999-06-17
NO20074419L (no) 2000-06-02
CN1152685C (zh) 2004-06-09
NO20002777L (no) 2000-06-02
EP1035851B1 (de) 2001-08-16
RU2292891C2 (ru) 2007-02-10
ATE204172T1 (de) 2001-09-15
NO324694B1 (no) 2007-12-03
RU2003138080A (ru) 2005-06-10
DE59801230D1 (de) 2001-09-20

Similar Documents

Publication Publication Date Title
ES2304795T3 (es) Anticuerpos agonistas para el receptor de trombopoyetina y sus usos terapeuticos.
FI960953A0 (fi) Endoteliinireseptoriantagonisteja
NO20074419L (no) Anvendelse av endotelinreseptorantagonister for fremstilling av medikamenter for a bekjempe sykdom
FI961251L (fi) Ihmisten metabotrooppiset glutamaattireseptorialatyypit(HMR4, HMR6, HMR7)ja niihin liittyvät DNA-yhdisteet
ATE360032T1 (de) Cystein-reiche rezeptoren-train
BR9612779A (pt) Antagonistas ao receptor de il-8
PT911340E (pt) Isoquinolinas-3-carboxamidas substituidas, sua preparacao e utilizacao como farmacos
ES2128735T3 (es) Composiciones farmaceuticas que comprenden un antagonista de opiaceos y de sales de calcio y su uso para el tratamiento de patologias en las que intervienen las endorfinas.
EE9900304A (et) Tsentraalse kannabioidretseptori antagonistide kasutamine apetentsi reguleerimiseks
EP0837927A4 (en) MONOCLONAL MONKEY ANTIBODIES AGAINST HUMANE B7.1 AND / OR B7.2 ANTIGEN, PRIMATIZED DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS
BR0110968A (pt) Antagonistas dos receptores de il-8
DE69429861D1 (de) Endothelin-rezeptor-antagonisten
BR9909486A (pt) Compostos calcilìticos
IT1306560B1 (it) Dispositivo di regolazione e limitazione della miscela percarburatore.
ES2171196T3 (es) Uso de antagonistas del receptor cck-b para el tratamiento de trastornos del sueño.
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
ITTO960496A0 (it) Modificatione di farmaci polipeptidici per accrescere il flusso per e-lettrotrasporto.
MX9606179A (es) Agonistas y antagonistas de los receptores del acido acetilcolina nicotinico de insectos para el control de endoparasitos.
NO972612D0 (no) Pyridazoner som endotelinreseptorantagonister
BR9812531A (pt) Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica
ES2152315T3 (es) Xamoneline tartrato.
FR2791974B1 (fr) Composition ceramique piezo-electrique et vibreur et actuateur l'utilisant
DE69203803D1 (de) Abstandselement als zusatz zu dübelverankerungsvorrichtungen für wandbekleidungsplatten.
NO20001894D0 (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
FI971528A7 (fi) Pyrrolyylitetrahydrobentsokinoksaliinidionit, niiden valmistus ja käyt tö glutamaattireseptoriantagonisteina

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B25A Requested transfer of rights approved

Free format text: ABBOTT GMBH (DE)

B25D Requested change of name of applicant approved
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE ACORDO COM OS ARTIGOS 8O, 24 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.